DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021" report has been added to ResearchAndMarkets.com's offering.
The global pharmaceutical drug market was worth $934.8 billion in 2017 and has grown at a CAGR of 5.16% during 2013-2017. The market is expected to grow at a CAGR of 5.78% during 2017-2021 and is forecast to be worth $1,170.4 billion by 2021.
Global GDP is expected to grow significantly to 2021, so the 5.78% annual growth of the global pharma market does not register in the percentage figures. Aging populations, income growth especially in emerging economies and the high prices of new drugs are factors leading to steadily increasing per capita drugs expenditure.
At the global level, pharmaceutical drugs are segmented based on the therapeutic area with drugs for musculoskeletal disorders as the largest segment worth $130.2 billion in 2017. Cardiovascular drugs were the second largest segment followed by oncology drugs with a market worth $129.6 billion and 125.9 billion respectively. Ophthalmology Drugs was the smallest major segment in the pharmaceutical drugs market worth about $27.7 billion.
Key Topics Covered:
- Executive Summary
- Pharmaceutical Drugs Market Characteristics
- Global Pharmaceutical Drugs Market, PESTLE Analysis
- Pharmaceutical Drugs Market Customer Information
- Pharmaceutical Drugs Market Regional And Country Analysis
- Global Pharmaceutical Drugs Market Segmentation
- Pharmaceutical Drugs Market Segments And Subsegments
- Pharmaceutical Drugs Market Comparison With Macro Economic Factors
- Pharmaceutical Drugs Market Comparison With Industry Metrics
- Global Pharmaceutical Drugs Market Competitive Landscape
- Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
- Pharmaceutical Drugs Market Trends And Strategies
- Market Background: Healthcare Market
Companies Mentioned
North America:
- 3M Pharmaceuticals
- Abbott Laboratories
- AbbVie
- Amgen
- Astellas Pharma
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Gilead Science
- Johnson & Johnson
- Merck & Co.
- Pfizer Inc.
- Q Pharm
Asia-Pacific:
- Cipla
- Daiichi Sankyo
- Dr. Reddy's Laboratories Ltd.
- Otsuka Pharmaceutical Co. Ltd.
- Shanghai Fosun Pharmaceutical
- Shanghai Pharmaceuticals
- Sun Pharma
- Takeda Pharmaceutical Company Ltd.
Western Europe:
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- GlaxoSmithKline
- Novartis
- Novo Nordisk
- Roche
- Sanofi
- Teva Pharmaceutical Industries
South America:
- Ache
- AstraZeneca
- Bayer
- Biolab Farmaceutica
- Boehringer Ingelheim
- Cristalia
- EMS Pharma
- Eurofarma
- GlaxoSmithKline
- Hypermarcas
- Libbs
- Medley
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi
- Takeda
- Teuto Brasileiro
- Unio Quimica
- Eatern Europe:
- AKRIKHIN
- Aventis
- Bayer
- GlaxoSmithKline
- Microgen
- Novartis
- Pfizer
- Pharmstandard
- Roche
- Sanofi
- Sotex
- STADA CIS Russian Holding
Middle East:
- Abbott Laboratories
- GSK
- Gulf Pharmaceutical Industries (Julphar)
- Merck
- Pfizer
- Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO)
Africa:
- Adcock Ingram
- Aspen
- Bayer
- Cipla
- Johnson & Johnson
- Novartis
- Pfizer
- Roche
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/vhkth9/global?w=4
